This Trend is Excellent News for Eli Lilly and Its Investors
Eli Lilly and Novo Nordisk are vying for a new part of the weight loss drug market.
Eli Lilly and Novo Nordisk are vying for a new part of the weight loss drug market.
Select a language and narrator voice before playback.